Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for prevention of delirium in ICU patients
IRCT20100816004578N8Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of melatonin in delirium (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoints: Delirium incidence and Number of admission days. Started Aug 2019; status: completed.
02
Drugs
melatonin
03
Conditions
delirium
Beyond the preview
Go deeper on IRCT20100816004578N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100816004578N8.